ACU releases Q4 results this morning with short interest climbing 5% overnight. Borrowing costs have eased significantly over the past month.
Short interest stands at 82,174 shares, representing 2.16% of the free float.
The position jumped 5.1% in the last session to its highest level in three weeks. Over the past month, shorts added 2.6% to their positions, though the stock remains lightly shorted compared to most healthcare supply names.
Days to cover sits at 4.11 based on recent average volume.
No options data is available for ACU. The stock does not appear to have listed options.
No analyst ratings are currently available for Acme United. The company operates without formal Wall Street coverage.
ACU last reported earnings on March 6, 2026 at 11:30 AM ET. The company announced this quarter's print on April 15, confirming a 10:30 AM ET release today.
Price action shows the stock down 4.5% yesterday and off 3.3% over the past month. The shares closed at $43.48 on April 23.
No ORTEX Alpha signals are currently active on ACU.
The ORTEX Short Score stands at 40.96 out of 100, ticking up from 39.17 the prior session. This mid-range score reflects moderate short-side pressure relative to the stock's historical patterns.
Cost to borrow has dropped sharply, falling 21% over the past week and 54% over the past month to just 0.99%. Utilization climbed to 9.83%, up from 6.63% the day before, though still well below the 52-week high of 20.95%.
See the live data behind this article on ORTEX.
Open ACU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
